PCP. Chossegros

P. Chossegros

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


P. Chossegros has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A French prospective observational study of the treatment of chronic hepatitis C in drug abusers

    by P. Chossegros, P. Mélin, C. Hézode, M. Bourlière, S. Pol, A. Fhima, B. Filoche, C. Trépo, P. Couzigou, D. Ouzan, et al.


    • 1 February 2001
      • Vol. 25  (2) , 131-6

    [Patients with alcoholic liver disease hospitalized in gastroenterology. A national multicenter study].

    by S Naveau, V Giraud, N Ganne, P Perney, P Hastier, E Robin, F Pessione, P Chossegros, P Lahmek, H Fontaine, et al.

    To describe the characteristics of in-patients with alcoholic liver disease in Hepatogastroenterology and to evaluate whether geographic location was a risk factor for cirrhosis. A French, national, multicenter, prospective investigation was performed in the last quarter of 1997. To be included in the study, patients had to have drunk at least 50 g of alcohol per day for the past year or to have cirrhosis. Seventeen centers included 802 patients, 20% had histologically proven cirrhosis or probable cirrhosis. Thirty-five percent had undergone liver biopsy. Twenty five percent of these patients had cirrhosis without acute alcoholic hepatitis and 37% had cirrhosis with acute alcoholic hepatitis. After dividing France along a Bordeaux-Strasbourg axis, there was more histologically proven or probable cirrhosis in the North (46%) than in the South (36%) (P<0.005) while daily alcohol intake was greater the South (150 +/- 6 g) than in the North (129 +/- 4 g) (P<0.0001). When the six variables (age, sex, daily consumption of alcohol over the past 5 years, presence of hepatitis B surface antigen and antibodies to hepatitis C virus, total duration of alcohol abuse) were considered together in stepwise logistic regression analysis, geographic location changed the prediction of cirrhosis. The odds ratio for cirrhosis in patients living to the North of the Bordeaux-Strasbourg axis was 1.9 (95% confidence interval range 1.1-3.2) (P<0.02), suggesting the role of nutritional factors.


    • 1 April 1998
      • Vol. 125  (4) , 264-7

    [Epidermolysis bullosa acquisita and hepatitis C].

    by S Thiery, L Misery, P Chossegros, J Kanitakis, R Ghohestani, J Y Forestier, C Trepo, M Faure, A Claudy

    Epidermolysis bullosa acquisita is a bullous dermatosis. Its etiology remains unknown and the efficacy of its treatment is low. We report the first association between epidermolysis bullosa acquisita, chronic hepatitis C and cryoglobulinemia, healing with interferon alpha and ribavirine. We suggest a role for hepatitis C virus in the pathogenesis of epidermolysis bullosa acquisita. We suppose a synthesis of autoimmune antibodies in a dysimmune environment. Interferon alpha and ribavirine might be a new therapeutic avenue but further studies are necessary to confirm it.

    • 1 January 1996
      • Vol. 20  (3) , 269-80

    [Liver, biliary tracts and human immunodeficiency virus infection. 1:q liver, HIV and hepatitis B, C and D viruses].

    by D A Vuitton, P Chossegros, S Bresson-Hadni, J F Delfraissy, A Kirn, P Marcellin, S Pol, M C Saint-Paul


    • 1 January 1996
      • Vol. 20  (3) , 281-93

    [Liver, biliary tracts and human immunodeficiency virus infection. 2: hepatobiliary complications of AIDS].

    by D A Vuitton, P Chossegros, S Bresson-Hadni, J F Delfraissy, A Kirn, P Marcellin, S Pol, M C Saint-Paul

  • Should hepatitits-C virus antibody-positive donors be excluded from kidney donation?

    by C. Pouteil-Noble, J. C. Tardy, P. Chossegros, C. Trepo, M. Aymard, J. L. Touraine

    In organ transplantation, virus transmitted by the donor is associated with a higher risk of severe primary infection after transplantation in the seronegative recipient. In this study, the risk of hepatitis‐C virus (HCV) transmission by the kidney was determined, and the morbidity in the recipient assessed. Serum samples from all kidney donors of our Transplantation Unit between 1983 and 1988 were screened for antibodies to anti‐HCV by first enzyme‐linked immunosorbent assay (Ortho ELISA) and positive samples were confirmed by a second‐generation ELISA and the CHIRON RIBA HCV test. Of the 164 kidney donors whose sera were available, five were positive (3%) and all of them were positive with the RIBA test. Liver function was normal in the five donors. Seven recipients received a renal transplant from the anti‐HCV‐positive donors. Two patients had a follow‐up too short to draw any conclusions. Two patients remained anti‐HCV‐negative up to 36 and 48 months, respectively, but one of them had chronic hepatitis. One patient was anti‐HCV‐positive before transplantation and remained positive over the 4‐year follow‐up. The two last patients seroconverted and acute hepatitis occurred at 16 and 101 days after transplantation, respectively. In both cases, no peroperative or postoperative transfusion was given and no other cause of hepatitis could be determined. A cirrhotic evolution was observed within 15 and 36 months in both cases. Thus HCV can be transmitted by a kidney transplant and cadaveric donors positive for anti‐HCV antibodies should be excluded from kidney donation.


    • 1 January 1987
      • Vol. 138  (3) , 193-8

    [Satellite vasculitis of B or non-A non-B hepatitis. Diagnostic value of a provocation test by intradermal injection of histamine].

    by P Chossegros, R Wu, C Hermier, M S Doutre, R Brette, C Trepo

    The histo-pathological lesions of hypersensitivity vasculitis (HV) consist in an inflammatory reaction to circulating immune complexes deposited on the vascular endothelium. A provocation test by intradermal injection of histamine was used to demonstrate HV in patients with chronic hepatitis. Three groups of patients were studied: 16 with chronic hepatitis and HV, 22 with chronic hepatitis without HV, 4 control subjects. Skin biopsy was performed before and 3 hours after intradermal histamine. The following markers were looked for in the serum, skin and liver of all patients with chronic hepatitis: HBV (HBs Ag and HBe Ag, anti-HBs, anti-HBe and anti-HBc in the serum, HBs and HBc Ag in the liver); non-A non-B (non-A, non-B Ag and antibody, anti non-A non-Bc in the serum, non-A, non-Bc Ag in the liver). Viral antigens were found in healthy skin in 2 cases (1 chronic A hepatitis, 1 vasculitis), and after injection of histamine in 9 cases (4 chronic A hepatitis, 5 vasculitis). Viral antigens were found on skin biopsy in 2 patients with negative sera. Significant skin changes after histamine were detected only in HV (75 p. 100) even in the absence of cutaneous vasculitis (6/12 positive cases). An intradermal histamine provocation test is a simple, non-invasive method for diagnosing HV.


    • 1 November 1986
      • Vol. 15  (38) , 1934

    [Incidence of acute delta virus hepatitis].

    by P Chevallier, P Chossegros, C Trepo, M Sepetjan